Whole Foods Market opens new flagship in Southern California
TARZANA, Calif. Whole Foods Market announced that it is opening its newest flagship store in Tarzana, Calif.
According to company, the 30,000-sq.-ft. sales floor will feature all the local, natural and organic products that Whole Foods Market customers expect plus a collection of specialties designed to bring the community’s favorite international flavors to Whole Foods Market’s newest location. The store will feature sit-down eateries, a wine bar and the largest olive bar in Los Angeles, according to Whole Foods.
“On behalf of the store’s 200 team members and our local businesses, farmers and vendor partners, I would like to thank the Tarzana community for the warm welcome,” said George Khoury, Whole Foods Market Tarzana store team leader. “We are proud to be a part of this exciting and unique neighborhood and look forward to building strong relationships with our neighboring businesses and families. We hope to be more than your local grocery store — we’d love to be your neighborhood gathering place.”
CVS Caremark Charitable Trust supports flood relief efforts
WOONSOCKET, R.I. The CVS Caremark Charitable Trust is donating $100,000 to the American Red Cross Disaster Relief Fund to support flood relief efforts in the southeastern United States, including the states of Alabama, Mississippi and Tennessee.
In addition to the cash donation, the foundation is donating more than $13,000 in food and personal care items to the Seventh Day Adventist Center in Albertville, Ala., and the American Red Cross in Nashville. The donated product will be distributed to flood victims in these local communities.
“The Red Cross has implemented a coordinated effort to assist victims of these devastating floods and we are committed to supporting their efforts across the states that are impacted,” stated Eileen Howard Dunn, VP of the CVS Caremark Charitable Trust. “It is our hope that these funds will help these communities recover as quickly as possible.”
Keryx enrolls patients in Zerenex trial
NEW YORK Keryx Biopharmaceuticals has started a late-stage clinical trial of a drug for patients on kidney dialysis, the drug maker said Thursday.
Keryx plans to enroll around 150 people for a phase 3 trial of Zerenex (ferric citrate), a treatment for patients on kidney dialysis with elevated serum phosphorous levels, also known as hyperphosphatemia. The company started the short-term efficacy study Thursday and plans to start the long-term safety and efficacy study in third quarter 2010.
“I am pleased to be leading the registration program for Zerenex,” study chairwoman and Vanderbilt University medicine professor Julia Lewis said. “The clinical data generated to date suggests that Zerenex is an effective, safe and well-tolerated phosphate binder which we expect is differentiated form other marketed therapies by its iron composition and potential dosing convenience.”